Overview
Current guidance requires that we restrict attendance at NIH meeting. Please register for this year’s I-SCORE meeting only if you have been involved in the DCP Cancer Prevention Clinical Trials Network (CP-CTNet) program.
We thank you for your assistance and understanding.
The DCP Organ Systems Research Groups develop, support, and oversee clinical cancer prevention trials and promote participation by all populations. The trials are designed to evaluate the safety and efficacy of promising new preventive agents, the utility of novel biomarkers, and the value of innovative technologies to identify premalignant lesions. The Early Phase Cancer Prevention Clinical Trials Program facilitated through the grant funded Cancer Prevention Clinical Trials Network (CP-CTNet) was created to facilitate the efficient implementation of these studies by teams of multidisciplinary investigators. The purpose of the meeting is to stimulate information sharing and collaborations between DCP staff and CP-CTNet members including investigators, program staff and coordinators; and to develop strategies to enhance the cancer prevention intervention research program both scientifically and operationally.